Ankle Sprain 1St Degree, Ankle Sprain 2Nd Degree, Ankle Sprain 3Rd Degree
Conditions
Brief summary
Decathlon has developed Ankle STRONG products which are medical devices that must be positioned around the ankle to limit ankle sprain occurrence. The Ankle STRONG devices cover a range of 3 products (Ankle STRONG 100/500/900). The differences between the devices is based on the strength of compression and the ankle maintain. The objective of this multicentre study is to collect data on the related clinical complications and clinical outcomes of market-approved Decathlon Ankle STRONG products to demonstrate safety and performance of these devices in a real-world setting.
Interventions
DEVICEAnkleSTRONG100/500/900
At least 30 patients (15 patients in the orthosis group and 15 patients in the control group) per device type (3 device types: Ankle STRONG 100/500/900) totalling 90 patients will be included. Patients included in the orthosis group will use the device during sports sessions while patients included in the control group will not use an ankle support device.
Sponsors
EFOR, France
Decathlon SE
Study design
Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Subject is aged ≥ 18 years old * Subject has a recent mild OR moderate OR serious ankle sprain * The current condition of his/her ankle allows the subject to resume usual physical activity * Subject has been informed and is willing to sign an informed consent form * Subject is willing to comply with protocol requirements and return to the study center for all clinical evaluations and required follow-up (12 weeks) * Subject is affiliated to the French social security regime Non-inclusion Criteria: * Subject has conditions that may interfere with his/her ability to understand protocol requirements, participate in scheduled visits, or provide his/her informed consent * Subject has worn a support (ankle brace or articulated orthosis) since his/her recent injury * Subject has resumed regular physical activity since his/her recent injury * Subject has any medical condition that could impact the study at investigator's discretion * Subject has a known hypersensitivity or allergy to the components of the device (polyamide, elastane, polyester, cotton) * Adult subject to legal protection measure
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Functional score | 12 weeks of follow-up | Comparison of the functional result (Karlsson Ankle Function Score, 0-100 points) between the baseline and last follow-up visit in each group (orthosis vs control), for each device model |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Ankle pain | At 4 weeks, 8 weeks and 12 weeks of follow-up | Comparison of ankle pain, assessed through NRS (ranging from 0 to 10), between the groups (orthosis vs control), for each device model |
| Confidence level | At baseline and 12 weeks of follow-up | Gap in the confidence level (patient rated outcome with 6 questions, ranging from 0 to 100) related to physical activity, between the baseline and last follow-up visit in each group (orthosis vs control), for each device model |
| Ankle instability | At 4 weeks, 8 weeks and 12 weeks of follow-up | Comparison of ankle instability, assessed through a numerical rating scale (NRS, ranging from 0 to 10), between the groups (orthosis vs control), for each device model |
| Safety (adverse events) | 12 weeks of follow-up | Comparison of adverse events rates between the groups (orthosis vs control), for each device model |
Countries
France
Outcome results
None listed